Nexalin Technology, Inc.
Nasdaq · Healthcare · Electromedical & Electrotherapeutic Apparatus · Houston, TX
NXL chart
What traders are saying about $NXL
Latest postsNexalin Technology, Inc. news
- Nexalin Technology publishes results from 15 mA DIFS technology in Alzheimer’s
TipRanks ·
- Nexalin's 15 mA brain stimulation improves slee...
Pluang ·
- Nexalin Technology Announces Fourth Peer-Reviewed Publication in Alzheimer's Disease: 15 mA DIFS™ Significantly Improves Sleep Quality in Patients with Mild Alzheimer's Disease
Yahoo Finance ·
- Nexalin Technology, Inc. Estimates – NASDAQ:NXL
TradingView ·
- Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
Yahoo Finance ·
- Top Midday Gainers
Yahoo Finance ·
- Nexalin Technology Signs South America Distribution Agreement for Nexalin Sync Commercialization
investorshub.advfn.com ·
- Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation
Yahoo Finance ·
- Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization Strategy
Yahoo Finance ·
- Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Yahoo Finance ·
- Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study
Yahoo Finance ·
- Nexalin Technology Announces Reverse Stock Split
Yahoo Finance ·
Nexalin Technology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $301,647 | $168,721 | $110,748 | $1.3M |
| Net income | -$8.2M | -$7.6M | -$4.6M | -$1.7M |
| Diluted EPS | $-0.50 | $-0.83 | $-0.63 | $-0.30 |
| Total assets (year end) | $4.6M | $4.2M | $3.6M | $7.4M |
| Cash and equivalents (year end) | $654,783 | $574,485 | $580,230 | $162,743 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nexalin Technology, Inc.
- Ticker
- NXL (Nasdaq)
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1527352
Frequently asked questions
What exchange is Nexalin Technology, Inc. listed on?
Nexalin Technology, Inc. trades on the Nasdaq under the ticker symbol NXL.
What industry is Nexalin Technology, Inc. in?
Nexalin Technology, Inc. is classified by the SEC under "Electromedical & Electrotherapeutic Apparatus", part of the Healthcare sector on StockTweeting.
Where is Nexalin Technology, Inc. headquartered?
Nexalin Technology, Inc.'s business address on file with the SEC is in Houston, TX.
When does Nexalin Technology, Inc.'s fiscal year end?
Nexalin Technology, Inc.'s fiscal year ends on December 31.
How much revenue did Nexalin Technology, Inc. report?
Nexalin Technology, Inc. reported $301,647 in revenue for calendar year 2025, according to its SEC filings.